Menu
Washingtoner
  • Home
  • Boeing
  • Health
  • Aerospace
  • Daryl Guberman
  • Technology
  • Business
  • ANSI-ANAB
  • Non-profit
Washingtoner

FidaLab Announces Partnership With Ginkgo Bioworks to Scale COVID Response Through Pooled Testing in K-12 Schools
Washingtoner/10106886

Trending...
  • New plusOne Research Finds the Orgasm Gap Is a 30-Point Chasm — and Confirms It Isn't Biology
  • Five-star Review for Berklee School of Music Textbook
  • Melospeech Inc. Awarded New NYSDOH BEI Contract in New York
SEATTLE, April 9, 2021 /PRNewswire/ -- Today, FidaLab, a CLIA-certified clinical diagnostic company based in Seattle announced its partnership with Concentric by Ginkgo to provide a scalable and simple testing modality - pooled testing - to serve K-12 schools.

As more and more schools work to support in-person learning environments, communities across the country have turned to COVID-19 testing to monitor the virus. Even as teachers and guardians become eligible for vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts to track and mitigate viral spread remain critical.

Concentric by Ginkgo's goal is to provide easy, affordable pooled testing to every school in America. Pooled classroom testing, which combines swabs from all consenting individuals in a classroom and runs them as a single test can significantly increase testing capacity and lower the cost of testing programs. Over 800 hundred schools are currently signed up to test with Concentric across the country.

"We are excited at the prospect of joining Ginkgo to provide mass COVID testing in schools to help maintain in-person learning environments in Washington. Ginkgo has proven itself in successfully implementing school testing programs in the State of Massachusetts, Maryland, and beyond. The combination of our local testing capability and Ginkgo's experience and organizational strength will provide a very reliable option for Washington school systems," said Myles Yu, Chief Medical Officer of FidaLab.

More on Washingtoner
  • Scott Ritsema of Bisnar Chase Selected for 2026 National Traumatic Brain Injury Association
  • Flint Youth Film Festival Shifts Gears, Becomes Vehicle City Film Festival
  • Celebrate Tacoma's Top Volunteers and Service Providers at the 2026 City of Destiny Awards
  • 62% of Gen X have no estate planning documents — Trust & Will research identifies "the Sandwich Gap"
  • Nayarit's Jungle Coast Redefines Luxury Travel on Mexico's Pacific Now More Accessible Than Ever

On February 17, 2021, the U.S. Department of Health and Human Services (HHS) in partner with the Department of Defense (DOD) has announced a $650 million investment to expand COVID-19 testing capacity for K-8 schools to support President Biden's plan to re-open schools for in-person learning.

"The funding provided by the Biden Administration will help make it possible for schools in Washington and across the country to engage in pooled testing for every student, every week," said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. "Testing in schools will support the entire community by providing opportunities to limit the spread, and to interrupt chains of transmission."

FidaLab joined the fight against the COVID-19 pandemic at the very beginning and has built massive PCR testing capability for SARS-CoV-2, the virus that causes COVID-19. FidaLab has provided mass testing in collaboration with large scale county testing, schools, long term care facilities, athletic teams and more.

To learn more about Concentric by Ginkgo or to get your school district involved, head over to concentricbyginkgo.com.

About FidaLab

FidaLab is a privately owned CLIA-certified clinical laboratory based in Seattle with a specialty in molecular diagnosis of infectious diseases using cutting edge biotechnologies. With its proven diagnostic accuracy and 24-hour turnaround time, FidaLab has earned the trust of the communities it serves.

More on Washingtoner
  • $10 Million Annual Revenue Merger, Profitable Partner in AI Powered Specialty Automotive Sales Projected to Scale Above $200M: Stock Symbol: NWPG
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • RAS AP Consulting Launches Vendor Master File & Payment Controls Assessment for NACHA Phase 2 Compliance
  • Spokane: 2026 Wildfire & Forestry Safety Fair
  • Spokane AI Expert Adam Chronister to Discuss Authority Engineering at AI Roundtable Event

About Ginkgo Bioworks

Concentric by Ginkgo is Ginkgo Bioworks' public health and biosecurity effort. Headquartered in Boston, Ginkgo uses the most advanced technology on the planet—biology—to grow better products. The company's cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

Ginkgo Bioworks Contact:

[email protected]

FidaLab Contact:

[email protected]

Related Images

image1.jpg

SOURCE FidaLab LLC
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Statement from District 4 Council Member Sandesh Sadalge on Home in Tacoma Year One
  • 'Home in Tacoma' Sparks 62% Increase in Number of Proposed Housing Units in First Year
  • Food Journal Magazine Unveils Its Latest 'Best of Los Angeles' Culinary Discoveries
  • Boston Industrial Solutions Launches Natron® 717S Series: A New Flexible UV LED Ink for Ricoh GH2220 Printheads
  • 5 Things NYC Courier Services Won't Tell You About How Same-Day Delivery Actually Works
  • Spokane City Council Votes in Support of Moving Forward the STA Ballot Initiative
  • Tropidelic Links Up With International Reggae Star Collie Buddz and Eli Mac for Feel-Good Breakthrough Single "Follow Your Nature"
  • Save 15 Percent on Florida Keys Accommodations with KeysCaribbean's 'Advance Purchase Rate Discount'
  • Atelier 411 Studios and Columbus Fashion Council Present Red Carpet Experience at Gateway Film Center for The Devil Wears Prada 2
  • Hazel E Celebrates Birthday with Luxury "Goddess" Yacht Experience in Marina del Rey
  • Joseph Neibich sits down with Bold Jounrey (aka Joseph Nybyk)
  • AI Suite 360 Launches Done-For-You AI Implementation to Rescue SMBs from the "Frankenstein Tax"
  • Spokane: Mayor Brown Reestablishes City Arts Office, Names New Manager to Lead Effort
  • CX Network Releases Report on the Best AI Support Tools for SaaS Companies 2026
  • Outlier Pest Season Hits Willamette Valley as Mild Winter Drives Early Surge in Ant and Rodent Activity
  • Lokal Media House Wins Web Excellence Award for Black Plumbing Redesign
  • Lick Expands Flavored Massage Oil Collection with 10 New Indulgent Cream-Inspired Scents
  • New Research Identifies "Vacation Compatibility Gap" as the Hidden Force Shrinking How Long and With Whom Americans Travel
  • Melospeech Inc. Awarded New NYSDOH BEI Contract in New York
  • Five-star Review for Berklee School of Music Textbook
_catLbl0 _catLbl1

Popular on Washingtoner

  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19 - 101
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
  • Tacoma Police Department’s CALEA Public Comment Portal
  • Cinder Labs Launches AIRA Shield: Purpose-Built AI Security Platform to Combat Shadow AI

Similar on Washingtoner

  • $10 Million Annual Revenue Merger, Profitable Partner in AI Powered Specialty Automotive Sales Projected to Scale Above $200M: Stock Symbol: NWPG
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • RAS AP Consulting Launches Vendor Master File & Payment Controls Assessment for NACHA Phase 2 Compliance
  • Olga Torres Earns Repeat Recognition as a Top 2026 CFIUS Advisor
  • Strategic Talent Associates Launches THE ALIGNED RESET™
  • Calvetta Phair Founder & CEO Earns AOPA Foundation Flight Training Scholarship, Inspiring a New Generation of STEM Dreamers in Underserved Communities
  • 5 Things NYC Courier Services Won't Tell You About How Same-Day Delivery Actually Works
  • AI Suite 360 Launches Done-For-You AI Implementation to Rescue SMBs from the "Frankenstein Tax"
  • CX Network Releases Report on the Best AI Support Tools for SaaS Companies 2026
  • Five-star Review for Berklee School of Music Textbook
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute